• AO/PI Double Staining Kit: Advanced Cell Viability & Apoptos

  2026-07-04

  The AO/PI Double Staining Kit streamlines high-resolution detection of viable, apoptotic, and necrotic cells, enabling robust single-assay discrimination critical for cancer subtyping and rare cell analysis. With standardized workflows and actionable troubleshooting, this kit empowers translational researchers to achieve reproducible, high-impact results across fluorescence microscopy and flow cytometry platforms.

• SNS-032 (BMS-387032): Unraveling Host-Directed CDK Inhibitio

  2026-07-03

  Explore the advanced scientific rationale behind SNS-032 (BMS-387032), a selective CDK2/7/9 inhibitor, in both cancer and host-pathogen research. This cornerstone article uniquely dissects mechanistic insights and protocol decisions, offering a distinct perspective on the translation of CDK inhibition into innovative antiviral and oncology applications.

• Protease Inhibitor Cocktail: MS-Compatible Extraction Master

  2026-07-03

  Unlock uncompromised proteomic integrity with the Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) from APExBIO. Its AEBSF-free, broad-spectrum formula uniquely empowers mass spectrometry and stem cell workflows, ensuring reliable protein extraction even in the most demanding experimental contexts.

• Imipramine in Autophagy and Ceramide Pathways: A Cornerstone

  2026-07-02

  Explore how Imipramine, a tricyclic antidepressant, uniquely modulates autophagy and ceramide metabolism in cancer and neuroimmunology research. This article delivers a deeper mechanistic analysis and practical assay guidance, distinguishing itself from existing content.

• Vardenafil HCl Trihydrate: Precision Tool for PDE5 Inhibitio

  2026-07-02

  Vardenafil HCl Trihydrate sets a new benchmark for reliable, proteoform-specific PDE5 inhibition, accelerating both fundamental and translational smooth muscle research. Its unmatched potency, selectivity, and solubility empower advanced workflows in cGMP signaling and native membrane proteomics.

• Synergistic Inhibition of Pancreatic Cancer via CDK4/6 and B

  2026-07-01

  Gu et al. (2025) demonstrate that co-inhibition of CDK4/6 and BET proteins produces synergistic antitumor effects in pancreatic ductal adenocarcinoma by modulating the GSK3β-mediated Wnt/β-catenin pathway. Their findings clarify the paradoxical pro-metastatic effects of CDK4/6 inhibitors alone and support dual targeting as a promising strategy for Wnt-driven cancer therapy.

• LNP-Stabilized Emulsions Enable Spatiotemporal mRNA Delivery

  2026-07-01

  Zhou et al. introduce a lipid nanoparticle-stabilized emulsion (LSE) platform that achieves precise spatiotemporal control over mRNA delivery to immune cells. This approach enhances antigen presentation in antigen-presenting cells, resulting in robust and durable T cell responses that surpass those of traditional mRNA vaccine systems, with significant implications for antiviral and antitumor immunity.

• Tunable Human Intestinal Organoids: Balancing Self-Renewal a

  2026-06-30

  This study introduces a human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation using targeted small molecule modulation. The approach enhances cellular diversity and proliferative capacity under a single culture condition, advancing organoid scalability and utility for high-throughput applications.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn

  2026-06-30

  This Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) prevents unwanted protein degradation during extraction, especially in workflows sensitive to divalent cations. It is not suitable for applications requiring EDTA-based metalloprotease inhibition or those incompatible with DMSO.

• TH287 MTH1 Inhibitor Enhances Radiosensitivity in CRPC Cells

  2026-06-29

  A recent study demonstrates that the MTH1 inhibitor TH287 significantly sensitizes castration-resistant prostate cancer (CRPC) cells to ionizing radiation by increasing oxidative DNA damage, promoting apoptosis, and inducing cell cycle arrest. These findings establish optimal timing for combination therapy and provide a mechanistic basis for radiosensitization strategies in advanced prostate cancer research.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Optimizing Extrahepatic Deli

  2026-06-29

  EZ Cap™ Mouse IL-12 mRNA (m1Ψ) empowers immunotherapy research with stable, low-immunogenicity cytokine mRNA, ideal for advanced delivery systems like virus-mimicking nanoparticles. This workflow guide translates recent breakthroughs into actionable protocols, troubleshooting strategies, and future-focused applications.

• Biochemical Profiling of GOB-38 β-Lactamase in E. anophelis

  2026-06-28

  This study delineates the substrate specificity and structural features of the GOB-38 metallo-β-lactamase variant from Elizabethkingia anophelis, highlighting its broad antibiotic hydrolytic capacity and potential for resistance gene dissemination. The findings advance understanding of multidrug resistance dynamics, especially in clinical co-infections involving E. anophelis and Acinetobacter baumannii.

• Annexin V, Human Recombinant: Precision Timing in Early Apop

  2026-06-27

  Explore how Annexin V, a leading phosphatidylserine binding protein, enables unprecedented precision in tracking early apoptosis events. This article uniquely focuses on timing, in vivo applications, and methodological impact for advanced cell death research.

• Valemetostat Monotherapy in Relapsed/Refractory NHL: Phase 1

  2026-06-26

  This phase 1 study establishes Valemetostat (DS-3201) as a promising dual EZH1/2 inhibitor with clinically meaningful activity and a manageable safety profile in relapsed or refractory non-Hodgkin lymphoma. The findings provide a robust foundation for further development of epigenetic therapies targeting EZH2-driven lymphomas.

• Applied Use of Cell Counting Kit-8 (CCK-8) in Osteoclast Res

  2026-06-26

  The Cell Counting Kit-8 (CCK-8) streamlines sensitive cell proliferation and cytotoxicity assays, excelling in workflows demanding high throughput and quantitative rigor. Its water-soluble WST-8 chemistry outpaces legacy assays, as demonstrated in recent osteoclastogenesis research and broader cell viability studies.

445 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page